Search - tctmd.com

Displaying 601 - 616 of 616

Sort: Relevancy | Date

News Conference News TVT 2016

Teenage TAVR: Should Practice Forge on While Guidelines Grow Up?

Michael O'Riordan

June 20, 2016

News Daily News

患者在 TAVR 后感染性心内膜炎的死亡率高，应予以更好的预防和治疗

Yael L. Maxwell

June 15, 2016

News Daily News

La Alta Mortalidad que Sobreviene tras una Endocarditis Infecciosa Post-TAVR Justifica Mejores Medidas de Prevención y Tratamiento

Yael L. Maxwell

June 15, 2016

News Daily News

High Mortality Following Infective Endocarditis After TAVR Warrants Better Prevention, Treatment

Yael L. Maxwell

June 15, 2016

News Daily News

Liraglutide Leaps Over FDA Safety Hurdle, With Cardiovascular Mortality Reduction to Boot: LEADER

Michael O'Riordan

June 14, 2016

News Daily News

利伐沙班有助于溶解房颤患者的左心房血栓

Todd Neale

June 09, 2016

News Daily News

Rivaroxaban podría Ayudar a Disolver Trombos Auriculares Izdos. en Pacientes con FA

Todd Neale

June 09, 2016

News Daily News

Rivaroxaban May Help Dissolve Left Atrial Thrombus in Patients With A-fib

Todd Neale

June 09, 2016

News Daily News

大规模 Meta 分析显示，TAVR 与手术 30 天和 1 年死亡率相当

Michael O'Riordan

June 07, 2016

News Daily News

Según un Gran Meta Análisis Parecida Mortalidad al cabo de 30 Días y 1 Año con TAVR Versus Cirugía

Michael O'Riordan

June 07, 2016

News Daily News

Equivalent Mortality at 30 Days and 1 Year With TAVR vs Surgery, Says Large Meta-analysis

Michael O'Riordan

June 07, 2016

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for May 2016

Shelley Wood

May 31, 2016

News Conference News ACC 2016

Older Men With Existing Coronary Disease at Highest Risk of Dying During a Triathlon

Michael O'Riordan

April 06, 2016

News Daily News

Older Age Tied to Higher Risk of Recurrent Cerebral Ischemia in PFO Closure Patients

Yael L. Maxwell

July 08, 2015

Presentation

Quality-of-life Outcomes After TAVR in an Unselected Population

Presenter: Suzanne Arnold

February 06, 0017

CME

Advertisement

Teenage TAVR: Should Practice Forge on While Guidelines Grow Up?

患者在 TAVR 后感染性心内膜炎的死亡率高，应予以更好的预防和治疗

La Alta Mortalidad que Sobreviene tras una Endocarditis Infecciosa Post-TAVR Justifica Mejores Medidas de Prevención y Tratamiento

High Mortality Following Infective Endocarditis After TAVR Warrants Better Prevention, Treatment

Liraglutide Leaps Over FDA Safety Hurdle, With Cardiovascular Mortality Reduction to Boot: LEADER

利伐沙班有助于溶解房颤患者的左心房血栓

Rivaroxaban podría Ayudar a Disolver Trombos Auriculares Izdos. en Pacientes con FA

Rivaroxaban May Help Dissolve Left Atrial Thrombus in Patients With A-fib

大规模 Meta 分析显示，TAVR 与手术 30 天和 1 年死亡率相当

Según un Gran Meta Análisis Parecida Mortalidad al cabo de 30 Días y 1 Año con TAVR Versus Cirugía

Equivalent Mortality at 30 Days and 1 Year With TAVR vs Surgery, Says Large Meta-analysis

TCTMD’s Top 10 Most Popular Stories for May 2016

Older Men With Existing Coronary Disease at Highest Risk of Dying During a Triathlon

Older Age Tied to Higher Risk of Recurrent Cerebral Ischemia in PFO Closure Patients

Quality-of-life Outcomes After TAVR in an Unselected Population

TAVR: The Heart Team Approach

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content